Olink
Significant recent improvements in depth of coverage and throughput have substantial implications for both researchers and companies in the space.
Olink Q1 Revenues Jump 21 Percent on Strong Proteomic Kit Sales
The Uppsala, Sweden-based proteomics firm posted $27.5 million in revenues compared to $22.7 million a year ago, just above analysts' consensus estimate of $27.3 million.
GenomeWeb Top 40 Down 4 Percent in February, Tracking Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq was down 1 percent, and the Nasdaq Biotech Index was down 7 percent.
Olink Q4 Revenues Rise 32 Percent
The proteomics firm posted revenues of $57.9 million, up from $43.7 million in the year-ago period and above the consensus Wall Street estimate of $57.3 million.
Single-cell transcriptome sequencing and spatial omics technologies have helped pave the way for a traditionally genetics-focused crowd to pursue proteins.